Compare Adaptive Biotechnologies Corp (ADPT) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs MasTec Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while MasTec Inc trades at $277 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 5.4× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | MTZ | |
|---|---|---|
Market Cap | $4.04B | $21.90B |
Sector | Health | Technology |
52-Week High | $25.45 | $437.51 |
52-Week Low | $12.30 | $172.51 |
Enterprise Value | $4.10B | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
